Cells were left unstimulated or stimulated through the T cell receptor (TCR) in vitro allowing us to disentangle potential CD4+ T cell specific differences induced by T cell activation, providing novel insights into disease mechanisms of MS. This evidence concerns the gene CD4 and myeloid sarcoma.